Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder.

Author: EapChin B, KaneJohn M, PaulzenMichael, SchoretsanitisGeorgios, de LeonJose

Paper Details 
Original Abstract of the Article :
This article provides an overview of the pharmacokinetic drug-drug interactions (DDIs) for agents prescribed for attention-deficit/hyperactivity disorder (ADHD). Polypharmacy in the treatment of patients with ADHD leads to high exposures to DDIs and possibly adverse safety outcomes. We performed a s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40263-019-00683-7

データ提供:米国国立医学図書館(NLM)

Navigating Drug Interactions in ADHD Treatment

This research delves into the intricate world of drug interactions in the treatment of attention-deficit/hyperactivity disorder (ADHD). The study provides a comprehensive overview of pharmacokinetic drug-drug interactions (DDIs) for commonly prescribed ADHD medications, highlighting the potential risks associated with polypharmacy. The authors meticulously analyze DDI reports and provide valuable insights into the potential impact of these interactions on patient safety. The study underscores the importance of careful medication management and close monitoring for individuals with ADHD.

Understanding the Complexities of ADHD Medications

The study highlights the critical need to understand the potential for DDIs when treating ADHD, particularly when patients are prescribed multiple medications. The study provides a valuable resource for clinicians, outlining specific interactions and offering practical guidance for managing these risks. The study emphasizes the importance of proactive communication between healthcare providers and patients to ensure safe and effective treatment.

Navigating the Path to Safe and Effective Treatment

This study emphasizes the importance of vigilance and careful medication management in ADHD treatment. The study provides valuable information for clinicians and patients to minimize the risks associated with DDIs. Just as a camel navigates the treacherous desert terrain, we must navigate the complexities of medication interactions to ensure the safety and well-being of individuals with ADHD.

Dr. Camel's Conclusion

This study reminds us that the path to effective treatment for ADHD is often paved with complexities. We must be mindful of potential drug interactions and work closely with healthcare providers to ensure safe and effective treatment outcomes. Just as a camel adapts to the ever-changing desert landscape, we must adapt to the evolving knowledge of ADHD and its treatment.

Date :
  1. Date Completed 2020-09-18
  2. Date Revised 2020-09-18
Further Info :

Pubmed ID

31776871

DOI: Digital Object Identifier

10.1007/s40263-019-00683-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.